All patients
|
Unadjusted
|
1.22 (0.96–1.56)
|
0.10
|
1.29 (0.99–1.68)
|
0.055
|
Adjusted for local treatmenta
|
1.14 (0.87–1.51)
|
0.34
|
1.25 (0.93–1.68)
|
0.15
|
Adjusted for between the start of chemotherapy and starting local treatment
|
1.13 (0.88–1.45)
|
0.34
|
1.19 (0.91–1.56)
|
0.20
|
Adjusted for both local treatment and timing
|
1.11 (0.84–1.47)
|
0.46
|
1.21 (0.90–1.65)
|
0.21
|
Localised disease only
|
Unadjusted
|
1.31 (0.97–1.76)
|
0.08
|
1.39 (1.00–1.93)
|
0.048
|
Adjusted for local treatmenta
|
1.22 (0.87–1.72)
|
0.25
|
1.30 (0.89–1.90)
|
0.17
|
Adjusted for between the start of chemotherapy and starting local treatment
|
1.18 (0.87–1.60)
|
0.30
|
1.24 (0.88–1.74)
|
0.21
|
Adjusted for local treatment and the time between the start of chemotherapy and starting local treatment
|
1.14 (0.81–1.62)
|
0.45
|
1.20 (0.82–1.77)
|
0.35
|
Metastatic disease only
|
Unadjusted
|
0.98 (0.65–1.48)
|
0.93
|
1.01 (0.66–1.57)
|
0.94
|
Adjusted for local treatmenta
|
0.98 (0.61–1.56)
|
0.93
|
1.11 (0.68–1.81)
|
0.69
|
Adjusted for between the start of chemotherapy and starting local treatment
|
0.95 (0.62–1.45)
|
0.81
|
1.00 (0.64–1.57)
|
0.98
|
Adjusted for both local treatment and timing
|
0.99 (0.61–1.60)
|
0.97
|
1.14 (0.69–1.89)
|
0.60
|